Clinical Trial Update: Goal Achievement After a Change to Vortioxetine in Adults With Major Depressive Disorder [Phase 4]

View source ↗

Summary

A Phase 4 trial update reports goal achievement after a change to vortioxetine in adults with major depressive disorder; results completed and posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Vortioxetine (vortioxetine)

Snippet

Sponsor: Takeda | Conditions: Major Depressive Disorder | Phase 4 | Status: COMPLETED | Results posted: 2019-07-11